File Download
 
 
Supplementary

Conference Paper: HPV16 and HPV58 integrations in cervical cancer and premalignant lesions
  • Basic View
  • Metadata View
  • XML View
TitleHPV16 and HPV58 integrations in cervical cancer and premalignant lesions
 
AuthorsLiu, S
Chan, YK
Leung, R
Jiang, L
Luk, M
Lo, S
Fong, D
Cheung, A
Lin, Z
Ngan, H
 
Issue Date2011
 
Publisher27th International Papillomavirus Conference and Clinical Workshop.
 
CitationThe 27th International Papillomavirus Conference and Clinical Workshop, Berlin, Germany, 17-22 September 2011. In Abstract Book 3, 2011, p. 52, abstract P-24.29 [How to Cite?]
 
AbstractBACKGROUND: Genomic integration of the high-risk human papillomavirus (HPV) DNA into host genome is an important event in the cervical carcinogenesis from premalignant lesions to invasive cervical cancer. The viral DNA integration usually causes the deletion and/or disruption of HPV E2 gene, leading to the up-regulation of E6/7 viral oncoproteins. However, the prognostic value of the viral DNA integration in the prediction of the progression of premalignant lesions is still controversial. HPV16 and HPV58 are the most prevalent high-risk types found in cervical cancer and premalignant lesions in Chinese women, whereas the viral DNA integration status is unknown. OBJECTIVES: To assess the prevalence of HPV16 and HPV58 integrations in cervical cancer and premalignant lesions, as well as their clinical significance. Methods: Genomic DNAs were extracted from 110 HPV16 positive and 48 HPV58 positive cervical samples. HPV infection and genotyping was detected using INNO-LiPA HPV genotyping test. The integration state of the virus was measured by quantitative real-time fluorescent PCR with specific primers targeting E2 and E6 genes of HPV16 and HPV58, and determined by the E2/E6 ratio. RESULTS: HPV16 integration was detected in over 90% of the samples, counting 20 (95.2%) normal cervical samples, 12 (92.3%) ASCUS/low-grade CIN, 22 (95.7%) high-grade CIN and 53 (100%) cancers. Similarly, viral integration was also observed in most of the HPV58 positive samples (44 of 48, 91.7%), including 86.7% normal cervical samples and ASCUS/low-grade CIN, and 100% high-grade CIN and cancers. The integration status of HPV16/58 did not correlate with disease stages and patient survival. CONCLUSIONS: The HPV viral integration in host genome was a common phenomenon in HPV infected normal and cervical disease cases, suggesting that viral DNA integration may occur early in the cervical lesion progression.
 
DescriptionPoster Session 24 - Transformation and Carcinogenesis I: P-24.29
 
DC FieldValue
dc.contributor.authorLiu, S
 
dc.contributor.authorChan, YK
 
dc.contributor.authorLeung, R
 
dc.contributor.authorJiang, L
 
dc.contributor.authorLuk, M
 
dc.contributor.authorLo, S
 
dc.contributor.authorFong, D
 
dc.contributor.authorCheung, A
 
dc.contributor.authorLin, Z
 
dc.contributor.authorNgan, H
 
dc.date.accessioned2012-09-20T08:19:57Z
 
dc.date.available2012-09-20T08:19:57Z
 
dc.date.issued2011
 
dc.description.abstractBACKGROUND: Genomic integration of the high-risk human papillomavirus (HPV) DNA into host genome is an important event in the cervical carcinogenesis from premalignant lesions to invasive cervical cancer. The viral DNA integration usually causes the deletion and/or disruption of HPV E2 gene, leading to the up-regulation of E6/7 viral oncoproteins. However, the prognostic value of the viral DNA integration in the prediction of the progression of premalignant lesions is still controversial. HPV16 and HPV58 are the most prevalent high-risk types found in cervical cancer and premalignant lesions in Chinese women, whereas the viral DNA integration status is unknown. OBJECTIVES: To assess the prevalence of HPV16 and HPV58 integrations in cervical cancer and premalignant lesions, as well as their clinical significance. Methods: Genomic DNAs were extracted from 110 HPV16 positive and 48 HPV58 positive cervical samples. HPV infection and genotyping was detected using INNO-LiPA HPV genotyping test. The integration state of the virus was measured by quantitative real-time fluorescent PCR with specific primers targeting E2 and E6 genes of HPV16 and HPV58, and determined by the E2/E6 ratio. RESULTS: HPV16 integration was detected in over 90% of the samples, counting 20 (95.2%) normal cervical samples, 12 (92.3%) ASCUS/low-grade CIN, 22 (95.7%) high-grade CIN and 53 (100%) cancers. Similarly, viral integration was also observed in most of the HPV58 positive samples (44 of 48, 91.7%), including 86.7% normal cervical samples and ASCUS/low-grade CIN, and 100% high-grade CIN and cancers. The integration status of HPV16/58 did not correlate with disease stages and patient survival. CONCLUSIONS: The HPV viral integration in host genome was a common phenomenon in HPV infected normal and cervical disease cases, suggesting that viral DNA integration may occur early in the cervical lesion progression.
 
dc.description.naturelink_to_OA_fulltext
 
dc.descriptionPoster Session 24 - Transformation and Carcinogenesis I: P-24.29
 
dc.identifier.citationThe 27th International Papillomavirus Conference and Clinical Workshop, Berlin, Germany, 17-22 September 2011. In Abstract Book 3, 2011, p. 52, abstract P-24.29 [How to Cite?]
 
dc.identifier.epage52
 
dc.identifier.hkuros208679
 
dc.identifier.spage52
 
dc.identifier.urihttp://hdl.handle.net/10722/165572
 
dc.languageeng
 
dc.publisher27th International Papillomavirus Conference and Clinical Workshop.
 
dc.publisher.placeGermany
 
dc.relation.ispartofAbstract Book 3 - Basic Science
 
dc.titleHPV16 and HPV58 integrations in cervical cancer and premalignant lesions
 
dc.typeConference_Paper
 
<?xml encoding="utf-8" version="1.0"?>
<item><contributor.author>Liu, S</contributor.author>
<contributor.author>Chan, YK</contributor.author>
<contributor.author>Leung, R</contributor.author>
<contributor.author>Jiang, L</contributor.author>
<contributor.author>Luk, M</contributor.author>
<contributor.author>Lo, S</contributor.author>
<contributor.author>Fong, D</contributor.author>
<contributor.author>Cheung, A</contributor.author>
<contributor.author>Lin, Z</contributor.author>
<contributor.author>Ngan, H</contributor.author>
<date.accessioned>2012-09-20T08:19:57Z</date.accessioned>
<date.available>2012-09-20T08:19:57Z</date.available>
<date.issued>2011</date.issued>
<identifier.citation>The 27th International Papillomavirus Conference and Clinical Workshop, Berlin, Germany, 17-22 September 2011. In Abstract Book 3, 2011, p. 52, abstract P-24.29</identifier.citation>
<identifier.uri>http://hdl.handle.net/10722/165572</identifier.uri>
<description>Poster Session 24 - Transformation and Carcinogenesis I: P-24.29</description>
<description.abstract>BACKGROUND: Genomic integration of the high-risk human papillomavirus (HPV) DNA into host genome is an important event in the cervical carcinogenesis from premalignant lesions to invasive cervical cancer. The viral DNA integration usually causes the deletion and/or disruption of HPV E2 gene, leading to the up-regulation of E6/7 viral oncoproteins. However, the prognostic value of the viral DNA integration in the prediction of the progression of premalignant lesions is still controversial. HPV16 and HPV58 are the most prevalent high-risk types found in cervical cancer and premalignant lesions in Chinese women, whereas the viral DNA integration status is unknown. OBJECTIVES: To assess the prevalence of HPV16 and HPV58 integrations in cervical cancer and premalignant lesions, as well as their clinical significance. Methods: Genomic DNAs were extracted from 110 HPV16 positive and 48 HPV58 positive cervical samples. HPV infection and genotyping was detected using INNO-LiPA HPV genotyping test. The integration state of the virus was measured by quantitative real-time fluorescent PCR with specific primers targeting E2 and E6 genes of HPV16 and HPV58, and determined by the E2/E6 ratio. RESULTS: HPV16 integration was detected in over 90% of the samples, counting 20 (95.2%) normal cervical samples, 12 (92.3%) ASCUS/low-grade CIN, 22 (95.7%) high-grade CIN and 53 (100%) cancers. Similarly, viral integration was also observed in most of the HPV58 positive samples (44 of 48, 91.7%), including 86.7% normal cervical samples and ASCUS/low-grade CIN, and 100% high-grade CIN and cancers. The integration status of HPV16/58 did not correlate with disease stages and patient survival. CONCLUSIONS: The HPV viral integration in host genome was a common phenomenon in HPV infected normal and cervical disease cases, suggesting that viral DNA integration may occur early in the cervical lesion progression.</description.abstract>
<language>eng</language>
<publisher>27th International Papillomavirus Conference and Clinical Workshop.</publisher>
<relation.ispartof>Abstract Book 3 - Basic Science</relation.ispartof>
<title>HPV16 and HPV58 integrations in cervical cancer and premalignant lesions</title>
<type>Conference_Paper</type>
<description.nature>link_to_OA_fulltext</description.nature>
<identifier.hkuros>208679</identifier.hkuros>
<identifier.spage>52</identifier.spage>
<identifier.epage>52</identifier.epage>
<publisher.place>Germany</publisher.place>
<bitstream.url>http://hub.hku.hk/bitstream/10722/165572/1/re01.htm</bitstream.url>
</item>